Table 2.
IHC score | SND1
|
AMACR
|
||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|
0 | 1 | 2 | 3 | Mean | P* | 0 | 1 | 2 | 3 | Mean | P* | |
No. cancer total | 2 | 14 | 40 | 6 | 1.8 | <0.0001 | 0 | 6 | 25 | 31 | 2.4 | <0.0001 |
No. PSA (ng/ml) | 0.012 | 0.85 | ||||||||||
<10 | 0 | 9 | 10 | 1 | 1.6 | 0 | 2 | 9 | 9 | 2.4 | ||
10<20 | 2 | 5 | 20 | 1 | 1.7 | 0 | 2 | 9 | 9 | 2.4 | ||
>20 | 0 | 0 | 9 | 3 | 2.3 | 0 | 0 | 6 | 6 | 2.5 | ||
No. Gleason score | 0.025 | 0.65 | ||||||||||
2<6 | 1 | 7 | 9 | 0 | 1.5 | 0 | 2 | 8 | 7 | 2.3 | ||
7 | 1 | 4 | 23 | 2 | 1.9 | 0 | 4 | 10 | 16 | 2.4 | ||
8<10 | 0 | 3 | 8 | 4 | 2.1 | 0 | 0 | 7 | 8 | 2.5 | ||
No. pathological stage | 0.95 | 0.60 | ||||||||||
pT2 | 1 | 8 | 25 | 4 | 1.8 | 0 | 4 | 16 | 18 | 2.4 | ||
pT3 | 1 | 5 | 16 | 2 | 1.8 | 0 | 2 | 9 | 13 | 2.5 | ||
No. HGPIN | 7 | 31 | 4 | 0 | 0.93 | 4 | 33 | 5 | 0 | 1.0 | ||
No. hyperplasia | 37 | 14 | 0 | 0 | 0.24 | 27 | 24 | 0 | 0 | 0.47 | ||
No. normal gland | 47 | 15 | 0 | 0 | 0.27 | 34 | 28 | 0 | 0 | 0.45 |
P value for differences mean score among groups of cancer, HGPIN, hyperplasia and normal gland, and each group of PSA. Gleason scores were assessed using the Kruskal-Wallis test. P value for difference between pT2 and pT3 was assessed using the Mann-Whitney U test.